<DOC>
	<DOCNO>NCT00444457</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability immunogenicity three lot 13-valent pneumococcal vaccine give healthy infant . Lots study consistency immune response , well non-inferiority safety compare 7-valent Pneumococcal Conjugate Vaccine .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criterion : Healthy 2 month old infant Available duration study reachable telephone Able complete two blood drawing procedure study Exclusion criterion : Previous vaccination , contraindication history allergic reaction vaccine vaccine component Bleeding disorder , immune deficiency significant chronic congenital disease Previous receipt blood product immune globulin</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Infants</keyword>
	<keyword>Pneumococcal Conjugate Vaccines</keyword>
	<keyword>Vaccines , Pneumococcal</keyword>
</DOC>